Background: NOVELTY (NCT02760329) is a global, prospective, observational study of patients with a physician-assigned diagnosis of asthma and/or COPD. Pre- and post-bronchodilator (BD) spirometry was performed at baseline. Objective: To compare spirometric markers of airflow obstruction and reversibility across the spectrum of obstructive lung disease.
|Publication status||Accepted/In press - 27 Jul 2020|
|Event||30th ERS International Congress - Virtual Event|
Duration: 7 Sep 2020 → 9 Sep 2020
|Conference||30th ERS International Congress|
|Period||7/09/20 → 9/09/20|
Hughes, R., Del Olmo, R., Make, B., Price, D., Agustí, A., Rapsomaniki, E., Müllerová, H., & Vestbo, J. (Accepted/In press). Comparison of spirometric markers of severity and reversibility in patients with asthma and/or COPD in NOVELTY. Abstract from 30th ERS International Congress, .